INcorporating VoIce acTivated Communication Aids Into Everyday

Status Recruiting

Clinical Trial Summary

Dysarthria is a speech disorder resulting in speech that is slow, slurred and difficult to understand, limiting a person's opportunities to study, work, and develop relationships. People with dysarthria often use communication aids to help them to communicate creating spoken messages using a keyboard, touchscreen or joystick. Communication aids can increase independence but are often too slow to keep pace with normal conversation. Developments in speech recognition technology have led to apps which can learn to recognise a set of words or sounds spoken by the individual with dysarthria, and connect these with a clear spoken output. The investigator's previous research provides some evidence that these voice input communication apps may be faster than traditional communication aids. This study aims to find out who can benefit from this technology, and what support they will need to use it successfully. This information can be used by professionals involved in providing communication aids, and will help the investigators to plan further research into their effectiveness. This research has two phases: 1. 20-30 individuals with dysarthria will be asked to use a voice input communication app for 6 months. The investigator's will collect information on whether VocaTempo improves their communication, and helps participants to reach their goals. 2. Focus groups will be held with professionals involved in providing and supporting people with communication aids, to understand factors affecting their ability to provide the support identified as needed in part 1 of the research. The investigators have a panel of communication aid users, who are advising and contributing throughout the study, for example, helping the investigators to identify informal support networks to recruit participants from. The investigators will let people know about the findings through support groups used by people with dysarthria, publications read by people involved in providing communication aids, and academic papers and conferences.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Dysarthria

Clinical Trial Details

NCT number	NCT05859438
Study type	Interventional
Source	University of Sheffield
Contact	Kate Fryer, PhD
Phone	07726597377
Email	k.fryer@sheffield.ac.uk
Status	Recruiting
Phase	N/A
Start date	May 2023
Completion date	July 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03605381` - MORbidity PRevalence Estimate In StrokE
Recruiting	`NCT03972202` - The Role of Cerebellum in Speech	N/A
Recruiting	`NCT06094205` - Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)	N/A
Recruiting	`NCT05724173` - Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia	N/A
Recruiting	`NCT05493670` - Subthalamic Nucleus Deep Brain Stimulation in Speech Study
Recruiting	`NCT03676439` - Lateral Cord Magnetic Stimulation For Refractory Spastic Cerebral Palsy	Phase 2/Phase 3
Recruiting	`NCT05741853` - Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia	N/A
Withdrawn	`NCT03142217` - Characterization of the Profile of Dysarthria in Huntington's Disease, Using the Clinical Evaluation Battery of Dysarthria	N/A
Completed	`NCT00123084` - Efficacy of Voice Treatment for Parkinson's Disease	N/A
Completed	`NCT00488657` - Improve Speech Using an In-the-ear Device in Parkinson's Disease	Phase 1
Completed	`NCT02705326` - Evaluating the Efficacy of Opti-Speech for Speech Treatment	N/A
Recruiting	`NCT02753192` - Dysarthria in Parkinson's Disease: Lusophony vs. Francophony Comparison	N/A
Completed	`NCT01684670` - Intensive Dysarthria Sessions in Adults and Children With Down Syndrome	N/A
Completed	`NCT03380676` - Study of Speech Disorders , Voice and Swallowing in Primary Dystonia Oromandibular	N/A
Recruiting	`NCT04604444` - Changes in Neuroplasticity Following Intensive Rehabilitation of Aphasia and/or Apraxia of Speech	N/A
Recruiting	`NCT04189159` - Speech Motor Treatment in Cerebral Palsy	N/A
Completed	`NCT04780230` - Non-invasive Brain Stimulation to Enhance Treatment of Dysarthria Post-stroke	N/A
Completed	`NCT05244603` - Application of Ideal Binary Masking to Disordered Speech	Early Phase 1
Withdrawn	`NCT03770377` - Laryngeal Adaptation for Speech and Swallowing	N/A
Completed	`NCT04897711` - Perceptual Training to Improve Listeners' Ability to Understand Speech Produced by Individuals With Dysarthria	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

INcorporating VoIce acTivated Communication Aids Into Everyday Communication — INVITE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms